Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
about
Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysisAmitriptyline versus placebo for major depressive disorderThe past, present and future of psychiatric diagnosisPost-traumatic stress disorderThe Research Domain Criteria (RDoC) Project and Studies of Risk and Resilience in Maltreated ChildrenEarly intervention in psychosis: obvious, effective, overdueComorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates TreatmentAntidepressant efficacy of agomelatine: meta-analysis of published and unpublished studiesSelective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential AnalysisProgress and prospects in pharmacogenetics of antidepressant drugs.Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system.Lessons from community mental health to drive implementation in health care systems for people with long-term conditionsAre antidepressants clinically useful? Conclusion of a decade of debate.Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.A systematic approach to pharmacotherapy for geriatric major depressionIs the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatryImproving the uptake of systematic reviews: a systematic review of intervention effectiveness and relevanceADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity DisorderEfficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studiesEvidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyRandomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysisHow effective are common medications: a perspective based on meta-analyses of major drugs.To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials.Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions.Writing therapy: a new tool for general practice?Emergency department visits by adults for psychiatric medication adverse eventsCompeting commitments in psychiatric research: an examination of psychiatric researchers' perspectivesDo antidepressant medications work?No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.Recovery from chronic fatigue syndrome after treatments given in the PACE trialThe Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration.Evidence for the use of vilazodone in the treatment of major depressive disorder.Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.Medication efficacy: the impact of variability in defining and measuring ADHD and executive functioning.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.Pharmacometabonomics and personalized medicine.Burning issues in the meta-analysis of pharmaceutical trials for depression.
P2860
Q22251382-F7FA764E-B3DF-4037-AC72-3B4EA22273B2Q24202486-48C56E65-F8A3-489B-83A7-5DCB11AE5DEEQ24612496-D7238A74-D0A0-4FF5-8934-DEA3846C1ED9Q26776489-6FE91591-8E3A-4851-A355-BBA3B60F09DFQ26799558-83B9F655-3F16-4210-84A6-CC003239B004Q26859066-A0914892-992C-4D7D-B021-18CD0A130F6DQ27015872-6334750C-28A2-4DD2-B114-0197B5F8F75AQ28236293-B3589220-D129-4F19-BD30-896F560C7EFEQ28736049-E3082922-A8C1-41B1-BAA7-7ED877A2A827Q30249569-56413D41-BE0B-486D-B416-C40C19651830Q33597502-427829FE-2380-47E1-A67A-4F1917B29640Q33742232-9F77150F-47ED-462E-AE5C-D38159B66B1CQ33915538-38A15ABC-A4CE-44F9-BEA3-C988CC3A2384Q33921159-BB0D6B98-59F1-4F00-B0EE-70AD2D01E2C7Q34004408-9A37ABA4-F953-4D7C-B9C1-30B1C81E0A4DQ34159419-111E78A8-D7E2-4D7B-A77B-5F67EA91BAFAQ34357174-D2738192-6DDA-4D3A-8B6F-48AE9BCD2B6EQ34365032-A4AB11E3-613B-47BC-B7CE-E552B17FC72BQ34493964-5E1FA4C0-F841-41D5-8F4A-B83BA1F323C9Q34654500-5D67E207-CD3F-44B6-BA43-8D1FC8F52876Q34676317-CC1E1EFC-75C4-412F-8709-27D3F99ECE33Q35078619-E0650E91-311A-4735-9417-0678C3B6C010Q35797656-F26EB717-6BC5-49F9-A81B-B3A5571F406DQ35866297-0B7E5654-8F8E-419C-9AC9-8F92C345005CQ36077216-8B18BC31-DDA9-4662-BE88-26A6CAFACBB1Q36320887-457E87C9-045D-47CD-B860-A09875DD5859Q36420541-FFC0B663-A346-46BF-A012-B8B27DC2233AQ36436410-D55A04DD-82B2-4360-81AA-9FE6C30C5392Q36457196-60FE29D8-1E76-473C-A275-CA823B0DC2ACQ36801219-20808198-684D-4AEE-A3AC-49681EA91C0CQ37116846-523EC791-9E8C-43C9-97F6-DE5DF8E8CE7BQ37180409-9A7970C7-6592-46A6-8F0A-DA0D62D12D82Q37388486-6410878C-2D2F-4127-ADBD-F20F1D262D13Q37452489-55ABEB95-F68D-450D-A110-8C1B17B7B816Q38042691-3F2CC00F-E784-4686-8B7A-A177ADAA5742Q38076126-DDAED5D6-6E2B-497B-934C-02ACAFDC7B4BQ38083348-7E56BCF2-0ADF-46B8-ADE9-E17D9CF70B19Q38123516-32FB76CA-7878-4B25-8DCC-E253790E23E8Q38124254-2D624A9B-AB77-4792-AAA6-1A8F29153647Q38138536-F128E121-F510-460F-9F4E-4DF84B0E0A54
P2860
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@ast
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@en
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@nl
type
label
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@ast
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@en
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@nl
prefLabel
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@ast
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@en
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@nl
P2093
P3181
P1476
Putting the efficacy of psychi ...... ctive: review of meta-analyses
@en
P2093
J. M. Davis
W. Kissling
P304
P3181
P356
10.1192/BJP.BP.111.096594
P407
P577
2012-02-01T00:00:00Z